Targeting Dendritic Cells to Treat Multiple Sclerosis

Nature Reviews Neurology - United Kingdom
doi 10.1038/nrneurol.2010.112
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeting Senescence to Delay Progression of Multiple Sclerosis

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2018English

Siponimod: A New Approved Oral Drug to Treat Multiple Sclerosis

NeuroPharmac Journal
2019English

Multiple Sclerosis-Linked and Interferon-Beta-Regulated Gene Expression in Plasmacytoid Dendritic Cells

Journal of Neuroimmunology
AllergyImmunologyNeurology
2012English

Managing the Oral Side-Effects of Medications Used to Treat Multiple Sclerosis

Australian Dental Journal
Dentistry
2017English

Mast Cells: The Key to Multiple Sclerosis?

World Journal of Neuroscience
2014English

Targeting Dendritic Cells: A Promising Strategy to Improve Vaccine Effectiveness

Clinical and Translational Immunology
AllergyImmunologyNursing
2016English

B Cells in Multiple Sclerosis

Autoimmunity
AllergyImmunology
2017English

Angioplasty Used to Treat Multiple Sclerosis Patients: A Potential Revolution in Health Care Technology

Revue interdisciplinaire des sciences de la santé - Interdisciplinary Journal of Health Sciences
2011English

Targeting Dendritic Cells With Antigen-Containing Liposomes

Cancer Research
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy